www.fdanews.com/articles/131886-j-38-j-closer-to-emerging-20-billion-blood-thinner-market

J&J Closer to Emerging $20 Billion Blood-Thinner Market

November 12, 2010

Johnson & Johnson (J&J) is making headway in the development of a new, potentially lucrative anti-clotting drug.
TheStreet